Science for Local Needs?

Countries are unlikely to solve a particular problem unless they have some level of research invested in the effort. The approach in this paper is to use malaria research as a proxy for effective exploitation of local scientific knowledge. We study the malaria-related research output in two countries, Brazil and India, with among the most advanced science and pharmaceutical capabilities in the developing world. We assess local relevance of science and also its integration with international research by looking at almost 60 years of scientific publications on malaria between 1945-2003.

Related Content

In 2016 two talks were given in the US's agricultural heartland, Iowa. Iowa is the hub for biotech research and economic development pressures in "new" manufacturing.

The talks were held in the Urban and Regional Planning program at the University of Iowa in Iowa City, and at the City and Community Planning program at the Iowa State University of Science and Technology in Ames.


With great pleasure we share a new 2018 book by former TCLab Fellow Jose Eustaquio Vieira Filho and the esteemed Albert Fishlow:  "Agriculture and industry in Brazil: innovation and competitiveness". Published by the Institute for Applied Economics Research (IPEA)

Economics is growing pluralist again. Student protests since about 2013 are growing, furthering this trend. Professors have joined in (not all of them, of course). Economists of different methods and historical and theoretical approaches are acknowledging the importance of co-existence.

Meet Jessica George, former aerospace engineer and M.S. candidate at the Urban Planning program at GSAPP. At TCLab our researchers' backgrounds boost their understanding of how economies change. Their training and commitment can bridge technological and industrial transformation to topics on urban and regional employment, health, and social protections.

A preventive HIV vaccine offers the best hope for ending the AIDS pandemic. Scientific evidence suggests that an HIV vaccine is possible, and funding for HIV vaccine research and development (R&D) has increased substantially in recent years. The speed of progress toward an HIV vaccine will depend on the management of the effort as well as on its scale, however, and organizational issues have been the subject of vigorous debate.